Abrdn Life Sciences Investors is a publicly traded investment company that focuses on identifying and investing in innovative companies within the life sciences sector

The firm aims to generate long-term capital appreciation by actively managing a diversified portfolio of life sciences firms, including those involved in pharmaceuticals, biotechnology, medical devices, and related fields. Through its strategic investments, the company seeks to capitalize on advances in healthcare technology and drive positive outcomes in patient care while delivering value to its shareholders.